Predict your next investment

HEALTHCARE | Drug Development
site.peptivir.com

See what CB Insights has to offer

Stage

Seed | Alive

Total Raised

$300K

Last Raised

$300K | 11 yrs ago

About Peptivir

PeptiVir is an early stage biopharmaceutical company focused on the development and commercialization of a conformationally-constrained, synthetic peptide-based vaccine platform for the prevention of viral diseases.

Peptivir Headquarter Location

12635 East Montview Blvd. Suite 127

Aurora, Colorado, 80045,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.